Research field (3):
Medical systems
, Semiconductors, optical and atomic physics
, Urology
Research keywords (8):
urothelial carcinoma
, Robotic surgery
, Laparoscopic surgery
, prostate carcinoma
, 前立腺肥大症
, sexual function
, Bladder endometriosis
, Endometriosis
Papers (152):
Yoshihiko Ogata, Jun Akatsuka, Yuki Endo, Hikaru Mikami, Masato Yanagi, Hayato Takeda, Yuka Toyama, Yoichiro Yamamoto, Go Kimura, Yukihiro Kondo. Index tumor location affected early biochemical recurrence after radical prostatectomy in patients with negative surgical margin: a retrospective study. BMC Urology. 2024. 24. 1
Hikaru Mikami, Syunya Noguchi, Jun Akatsuka, Hiroya Hasegawa, Kotaro Obayashi, Hayato Takeda, Yuki Endo, Yuka Toyama, Hiroyuki Takei, Go Kimura, et al. snRNAs from Radical Prostatectomy Specimens Have the Potential to Serve as Prognostic Factors for Clinical Recurrence after Biochemical Recurrence in Patients with High-Risk Prostate Cancer. Cancers. 2024. 16. 9. 1757-1757
Shunsuke Ikuma, Jun Akatsuka, Hayato Takeda, Yuki Endo, Tomonari Kiriyama, Tsutomu Hamasaki, Go Kimura, Yukihiro Kondo. Determining the clinicopathological significance of the VI-RADS ≧4 group: a retrospective study. BMC urology. 2024. 24. 1. 63-63
Yuki Endo, Jun Akatsuka, Hayato Takeda, Hiroya Hasegawa, Masato Yanagi, Yuka Toyama, Hikaru Mikami, Mikio Shibasaki, Go Kimura, Yukihiro Kondo. Real-World Insights into Efficacy and Safety of Enfortumab Vedotin in Japanese Patients with Metastatic Urothelial Carcinoma: Findings, Considerations, and Future Directions. Current oncology (Toronto, Ont.). 2024. 31. 2. 759-768
Hiroya Hasegawa, Jun Akatsuka, Shogo Imai, Yuki Endo, Masato Yanagi, Hayato Takeda, Tatsuya Inoue, Yuka Toyama, Go Kimura, Yukihiro Kondo. A case of renal abscess mimicking metastatic lesion in a patient with lung carcinosarcoma. Journal of Nippon Medical School = Nippon Ika Daigaku zasshi. 2023
Early switching to pembrolizumab during 1st -line platinum-based cytotoxic chemotherapy in patients with metastatic urothelial carcinoma
(ASCO-GU 2023 2023)
Prognostic impact of serum cytokeratin 19 fragments in patient with metastatic urothelial cancer treated with immune checkpoint inihibitors.
(ASCO-GU 2022 (American Society of Clinical Oncology Genitourinary Cancers Symposium) 2022)
Prognostic impact of serum cytokeratin 19 fragments in patient with metastatic urothelial cancer (mUC) treated with first-line chemotherapy
(ASCO-GU 2021 (American Society of Clinical Oncology Genitourinary Cancers Symposium) 2021)
Can serum cytokeratin 19 fragments predict postoperative early progression in patients with upper urinary tract urothelial carcinoma?
(ASCO-GU 2020 (American Society of Clinical Oncology Genitourinary Cancers Symposium) 2020)
Early clinical outcomes of transurethral enucleation with bipolar compared with transurethral resection in saline for Benign Prostatic Hyperplasia treatment.
(World Congress of Endourology @Abu Dhabi 2019)
Efficacy of Laparoscopic Partial Cystectomy with a Transurethral Resectoscope in Patients with Bladder Endometriosis: See-Through Technique (Nippon Medical School)
Work history (6):
2022/10 - 現在 Nippon Medical School Department of Urology Senior Lecturer
2018/10 - 2022/09 Nippon Medical School Department of Urology Assistant professor
2017/02 - 2018/09 Kitamurayama Hospital Department of Urology Medical director
2014/04 - 2017/01 Nippon Medical School Hospital Department of Urology assistant professor
2011/04 - 2014/03 Nasu Red Cross Hospital Department of Urology Vice director of Urology
2010/04 - 2011/03 Chibaken Saiseikai Narashino Hospital Department of Urology Doctor
Show all
Association Membership(s) (8):
Japan Anti-aging
, Japan Continence Society
, 日本がん治療学会
, JAPANESE SOCIETY FOR SEXUAL MEDICINE
, JAPAN SOCIETY OF UROLOGIC ONCOLOGY
, JAPANESE SOCIETY FOR ENDOSCOPIC SURGERY
, JAPANESE SOCIETY OF ENDOUROLOGY
, THE JAPANESE UROLOGICAL ASSOCIATION